These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1129729)

  • 21. Filling and refilling practices with diazepam and methyldopa.
    Scrivens JJ; Weber C; Sather M; Geck W
    Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909
    [No Abstract]   [Full Text] [Related]  

  • 22. Editorial: The ASHP council on clinical pharmacy and therapeutics.
    Zellmer WA
    Am J Hosp Pharm; 1974 Sep; 31(9):831. PubMed ID: 4423139
    [No Abstract]   [Full Text] [Related]  

  • 23. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Education vs restriction in rational use of antibiotics.
    Spector R; Heller AH
    Hosp Formul; 1978 Apr; 13(4):273-5. PubMed ID: 10306917
    [No Abstract]   [Full Text] [Related]  

  • 25. Automatic interchange policy for first-generation i.v. cephalosporins.
    Suzuki NT
    Am J Hosp Pharm; 1987 Mar; 44(3):505. PubMed ID: 3565404
    [No Abstract]   [Full Text] [Related]  

  • 26. [Are the recommendations of the drug committee followed? A comparison of the prescribing pattern of anti-angina drugs in general practice and hospitals in relation to the recommendations].
    Salomonsen H; Beierholm V
    Ugeskr Laeger; 1991 Aug; 153(34):2333-5. PubMed ID: 1897041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Criteria for choice of preparations in a drug committee].
    Lunde PK
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):37-40. PubMed ID: 1111161
    [No Abstract]   [Full Text] [Related]  

  • 28. American Society of Hospital Pharmacists. Product selection survey.
    Am J Hosp Pharm; 1972 Jun; 29(6):506. PubMed ID: 5035970
    [No Abstract]   [Full Text] [Related]  

  • 29. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational drug use (II): Hospital drug and therapeutics committees.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Sep; 46(9):256-9. PubMed ID: 11320773
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of drug statistics in hospitals].
    Skobba TJ; Lunde PK
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):40-1. PubMed ID: 1111162
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategies for deleting popular drugs from a hospital formulary.
    Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
    Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy service: what are the goals of the pharmacy and therapeutics committee?
    Francke DE
    Hospitals; 1967 Oct; 41(20):99-100 passim. PubMed ID: 6065407
    [No Abstract]   [Full Text] [Related]  

  • 34. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug committee--an example of a quality circle].
    Hammershøy E; Christensen U; Christensen I
    Ugeskr Laeger; 1991 Aug; 153(34):2330-3. PubMed ID: 1897040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug committees, choice of drugs and drug information].
    Lundh B
    Lakartidningen; 1988 Nov; 85(44):3641-3. PubMed ID: 3199994
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug usage evaluation of warfarin sodium: the need for improved patient education.
    Hartwig SC
    Hosp Formul; 1992 Mar; 27(3):287-8, 300, 302. PubMed ID: 10116495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Editorial: Information committee of the drug industry].
    Naes K
    Tidsskr Nor Laegeforen; 1975 Oct; 95(30):1748-9. PubMed ID: 1188879
    [No Abstract]   [Full Text] [Related]  

  • 40. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.